Australian biotech market today 22.05.09
Friday, 22 May, 2009
As of 3.30pm, Healthcare index is down 1% on the back of a general 1.3% drop experienced by the All Ordinaries sparked by global economic concerns.
CSL dropped 50c to $30.90 and ResMed (ASX:RMD) is also down fractionally, along with the rest of the market.
Cochlear (ASX:COH) bucked the trend by rising $1.01 to $53.01, as did Ramsay Health Care (ASX:RHC), which gained 1.1%.
Ansell (ASX:ANN) shed 39 cents to $8.21 after Barclays Group issued a notice of ceasing to be a substantial holder from 18 May.
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
